Left Bundle Branch Pacing Versus Right Ventricular Pacing in Patients With Atrioventricular Block
1 other identifier
observational
1,000
1 country
1
Brief Summary
Although emerging evidence demonstrated that left bundle branch pacing (LBBP) is a promising alternative for patients with either a bradycardia or a heart failure pacing indication. However, a direct comparison of the safety, efficacy and LV systolic synchrony between LBBP and RVP regimens was rare. In this study, the investigators aim to conduct a comparison of the safety and effectiveness performance between these two pacing methods for patients with atrioventricular block (AVB). The investigators focused on AVB patients undergoing permanent pacemaker implantations from the 1st of January 2018 to the 18th of November 2021 at West China Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedFebruary 10, 2023
February 1, 2023
1 month
January 31, 2023
February 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
composed of all-cause mortality, lead failure and heart failure hospitalization (HFH) during the follow-ups
composed of all-cause mortality, lead failure and heart failure hospitalization (HFH) during the follow-ups
through study completion, an average of 2.45 year
Lead failure
reintervention for increased pacing thresholds, lead dislocation or ventricular perforation after the initial implantation procedure
through study completion, an average of 2.45 year
HFH
HFH was defined as the admission to hospital for \>24 hours with worsening symptoms and signs of heart failure and requiring one or more intravenous diuretics or intravenous inotropic medications
through study completion, an average of 2.45 year
Secondary Outcomes (3)
peri-procedure complication
through study completion, an average of 2.45 year
cardiac death
through study completion, an average of 2.45 year
recurrent unexplained syncope
through study completion, an average of 2.45 year
Study Arms (1)
high-grade AVB patients undergoing permanent pacemaker implantations
Interventions
After recording the His potential, the 3830-69 lead (Medtronic Inc., Minneapolis, MN USA) was sent 1-2 cm forward and downward to find the insertion point of the right side of intra-ventricular septum combined with the pre-rotation impedance and ECG changes. Ultimately, the tip was perpendicularly straightforward posited against the septum to the left septal side .
Right ventricular pacing (RVP) is the standard treatment for patients with continuous ventricular pacing needs.
Eligibility Criteria
consecutively high-grade AVB patients undergoing permanent pacemaker implantations from the 1 s t of January 2018 to the 18 thof November 2021 at West China Hospital
You may qualify if:
- included consecutively high-grade AVB patients undergoing permanent pacemaker implantations from the 1 s t of January 2018 to the 18 thof November 2021 at West China Hospital
You may not qualify if:
- patients with pacemaker replacements were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West China Hospital, Sichuan University
Sichuan, Sichuan, 610041, China
Related Publications (1)
Chen Z, Xu Y, Jiang L, Zhang R, Zhao H, Liu R, Zhang L, Li Y, Liu X. Left Bundle Branch Area Pacing versus Right Ventricular Pacing in Patients with Atrioventricular Block: An Observational Cohort Study. Cardiovasc Ther. 2023 Aug 21;2023:6659048. doi: 10.1155/2023/6659048. eCollection 2023.
PMID: 37645544DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr, cardiology department, principal investigator
Study Record Dates
First Submitted
January 31, 2023
First Posted
February 10, 2023
Study Start
January 1, 2023
Primary Completion
February 1, 2023
Study Completion
April 1, 2023
Last Updated
February 10, 2023
Record last verified: 2023-02